Appleton Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Appleton Partners's AGN Position: Q4 2018 in Review
Appleton Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,360 shares — an estimated $259K sold.
Appleton Partners first reported a position in AGN in Q2 2015 and held it in 14 quarters. The position peaked at $6.91M in Q2 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Appleton Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Appleton Partners sold 1,360 Allergan plc shares in Q4 2018, an estimated $259K.
- Appleton Partners first reported a position in Allergan plc in Q2 2015 and held it in 14 quarters.
- Appleton Partners's Allergan plc position peaked at $6.91M in Q2 2016.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Appleton Partners's 13F filing for Q4 2018, filed 17 Jan 2019.